These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28034550)

  • 1. Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance.
    May SM; Motosue MS; Park MA
    J Allergy Clin Immunol Pract; 2017; 5(3):831-833. PubMed ID: 28034550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypersensitivity cross-reaction with dapsone and cotrimoxazole in a patient infected by the human immunodeficiency virus].
    Jiménez-Lozano I; Alcalde M; Campany Herrero D; Monterde J
    Farm Hosp; 2013; 37(4):335-6. PubMed ID: 24010695
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia.
    Blum RN; Miller LA; Gaggini LC; Cohn DL
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):341-7. PubMed ID: 1548570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
    Barber BA; Pegram PS; High KP
    Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
    Beumont MG; Graziani A; Ubel PA; MacGregor RR
    Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
    Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
    Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals.
    Jorde UP; Horowitz HW; Wormser GP
    AIDS; 1993 Mar; 7(3):355-9. PubMed ID: 8471198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
    Urbancic KF; Pisasale D; Wight J; Trubiano JA
    Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
    James CW; McNelis KC; Szabo S
    Am J Health Syst Pharm; 2003 Aug; 60(15):1572-4. PubMed ID: 12951757
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A; Murri R; Ammassari A
    AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumocystis carinii dihydropteroate synthase mutations and treatment with sulfa or sulfone regimens: a proposal for standardized definitions for clinical evaluation.
    Huang L; Morris AM; Beard CB
    J Eukaryot Microbiol; 2001; Suppl():180S-181S. PubMed ID: 11906054
    [No Abstract]   [Full Text] [Related]  

  • 14. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
    JAMA; 1991 Apr; 265(13):1637-40, 1643-4. PubMed ID: 1672167
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Virologic Control and Severe Pneumocystis pneumonia in an HIV-Infected Patient Receiving Chemotherapy for Non-Small Cell Lung Cancer.
    Doll M; Kleinberg M; Kokh D; Riedel DJ
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):4-5. PubMed ID: 26325000
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
    Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
    Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of dapsone in the treatment of Pneumocystis carinii pneumonia in a foal.
    Clark-Price SC; Cox JH; Bartoe JT; Davis EG
    J Am Vet Med Assoc; 2004 Feb; 224(3):407-10, 371. PubMed ID: 14765801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.